These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37849335)

  • 1. Huntington study group's neuropsychology working group position on best practice recommendations for the clinical neuropsychological evaluation of patients with Huntington disease.
    Considine CM; Rossetti MA; Anderson K; Del Bene VA; Anderson SA; Celka AS; Edmondson MC; Sheese ALN; Piccolino A; Teixeira AL; Stout JC
    Clin Neuropsychol; 2024 May; 38(4):984-1006. PubMed ID: 37849335
    [No Abstract]   [Full Text] [Related]  

  • 2. Huntington Study Group's Neuropsychology Working Group: Implementing Non-Motor Diagnostic Criteria.
    Considine CM; Rossetti MA; Del Bene VA; Anderson K; Anderson SA; Celka AS; Edmondson MC; Nelson-Sheese AL; Piccolino A; Teixeira AL; Stout JC
    Mov Disord Clin Pract; 2023 Dec; 10(12):1714-1724. PubMed ID: 38094638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and behavioral changes in Huntington disease before diagnosis.
    Paulsen JS; Miller AC; Hayes T; Shaw E
    Handb Clin Neurol; 2017; 144():69-91. PubMed ID: 28947127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.
    Anderson KE; van Duijn E; Craufurd D; Drazinic C; Edmondson M; Goodman N; van Kammen D; Loy C; Priller J; Goodman LV
    J Huntingtons Dis; 2018; 7(3):355-366. PubMed ID: 30040737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease.
    Mustafa AI; Corey-Bloom J; Beltran-Najera I; Snell C; Castleton J; Smith H; Gilbert PE
    Cogn Behav Neurol; 2022 Sep; 35(3):198-203. PubMed ID: 35830248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.
    Vinther-Jensen T; Larsen IU; Hjermind LE; Budtz-Jørgensen E; Nielsen TT; Nørremølle A; Nielsen JE; Vogel A
    Orphanet J Rare Dis; 2014 Jul; 9():114. PubMed ID: 25026978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Beglinger LJ; Duff K; Allison J; Theriault D; O'Rourke JJ; Leserman A; Paulsen JS
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):573-8. PubMed ID: 19882420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
    McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH;
    Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
    Sešok S; Bolle N; Kobal J; Bucik V; Vodušek DB
    Psychiatr Danub; 2014 Sep; 26(3):239-48. PubMed ID: 25191771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
    Paulsen JS; Smith MM; Long JD;
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1233-9. PubMed ID: 23911948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and social cognition deficits in Huntington's disease differ between the prodromal and the manifest stages of the condition: A scoping review of recent evidence.
    Cavallo M; Sergi A; Pagani M
    Br J Clin Psychol; 2022 Jun; 61(2):214-241. PubMed ID: 34651307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
    Lipsmeier F; Simillion C; Bamdadian A; Tortelli R; Byrne LM; Zhang YP; Wolf D; Smith AV; Czech C; Gossens C; Weydt P; Schobel SA; Rodrigues FB; Wild EJ; Lindemann M
    J Med Internet Res; 2022 Jun; 24(6):e32997. PubMed ID: 35763342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between the neurocognitive profile of Huntington Disease-Like 2 and Huntington Disease: Exploring the presence of double dissociations.
    Ferreira-Correia A; Anderson DG; Cockcroft K; Krause A
    Appl Neuropsychol Adult; 2022; 29(2):223-233. PubMed ID: 32149528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ideomotor limb apraxia in Huntington's disease: a case-control study.
    Hödl AK; Hödl E; Otti DV; Herranhof B; Ille R; Bonelli RM
    J Neurol; 2008 Mar; 255(3):331-9. PubMed ID: 18305889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease.
    Julayanont P; Heilman KM; McFarland NR
    Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study.
    Connors MH; Teixeira-Pinto A; Loy CT
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):15-20. PubMed ID: 31611263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognition, function and awareness of disease impact in early Parkinson's and Huntington's disease.
    Júlio F; Ribeiro MJ; Morgadinho A; Sousa M; van Asselen M; Simões MR; Castelo-Branco M; Januário C
    Disabil Rehabil; 2022 Mar; 44(6):921-939. PubMed ID: 32620060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.